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In the last years, the surface 69 kD differentiation 
antigen CD73 has been demonstrated to play a s~gnificant role 
in the activation of human T cells. Unlike other surface 
molecules involved in T cell activation, CD73 combines three 
distinct features: i) it has ecto-5'nucleotidase (5'NT) 
activity (E.C. 3.1.3.5); ii) it is linked to the cell membrane 
via a glycosyl phosphatidylinositol (GPI) anchor; iii) it can 
very effectively amplificate T cell activation even if it is 
expressed by a minority only (15-25%) of T cells. 
Role of CD73 in T cell activation 
Since CD73 is expected to regulate the uptake of 
extracellular purines by converting nontransportable 
nucleotides into readily transportable nucleosides, earlier 
studies explored the role of the purine salvage pathway in T 
cell activation. It was shown that the 5'NT activity was 
crucial for mitogen-stimulated T cells when their capacity to 
synthetise purine de novo is lost (1). When subsets studies 
showed that CD73 expression in T cells was mainly confined to 
CD8+ CD11b- cells conta~ning CTL precursors (2), functional 
studies were carried out to investigate whether CD73 was 
involved in CTL generation. These studies used competi ti ve 
biochemical inhibi tors of 5' NT (AOPCP) and cross-reacting 
antisera (3). The latter suppressed three different steps of 
cytotoxicity: recognition of stimulatory cells, activation of 
the cytotoxic program, and binding of target cells. AOPCP only 
suppressed the second step of cytoxici ty , suggesting that 
inhibition of the enzyme activity was not the only factor 
involved in the suppression of T cell activation. 
Deeper insights into the role of CD73 in T cell activation 
were obtained when more specific immunologic tools became 
available. The first was a polyclonal antiserum against human 
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CD73 (4). IF studies at the single cell level confirmed the 
distribution of CD73 in lymphoid subpopulations previously 
reported by radiochemical and cytochemical assays (4). More 
importantly, anti-human CD73 serum allowed to purify CD73+ 
cells and carryon functional analyses (5). It was demonstrated 
that CD73+ cells have a unique sensitivity to protein kinase C 
(PKC) activators (5). PKC plays a central role in the cascade 
of biochemical events initiated by T cell antigen stimulation. 
Even more interestingly, it was found that CD73 multivalent 
cross-linking by the polyclonal antiserum delivered activation 
signals in the presence of submitogenic concentrations of PMA 
(6). These data demonstrated that CD73 itself could transduce 
activating signals across the membrane (6). These results were 
confirmed and extended with monoclonal antibodies (mAbs). So 
far, at least 5 different mAbs have been produced againts CD73 
(lE9, 7G2, 5N2, 27.2, AD2). Functional studies have mostly been 
carried out with two of them (lE9, 7G2). The latter clearly 
initiate T cell activation, but they require additional 
signalling. First, they require cross-linking by a second 
antibody (6), monocytes (6), or plastic immobilization (7). 
Second, CD73 engagement requires costimulatory signals like PMA 
(6) or signals delivered through surface molecules like CD3 and 
CD2 (7). These data indicate that CD73 itself can transduce 
activating signals, but this is not enough to fully activate T 
cells. Rather, CD73 serves as an agonistic molecule to up-
regulate T cell activation initiated by antigen recognition 
(accessory molecule). This function is similar to that of other 
accessory molecules like CD4, CD8, CD5, CD28, CD44, CD45 etc •. 
Compared with these molecules, CD73 has some unique features 
like its enzyme activity and its GPI-linkage to the plasma 
membrane. Finally, although CD73 is expressed by a minority of 
T cells and is restricted to a specific subset of CD8+ 
lymphocytes, its agonistic activity is much more effective than 
other accessory molecules. CD28 is one of the best 
characterized accessory molecule which is expressed by more 
than 70% of T cells. Nevertheless, side by side experiments 
have shown that CD73 is much more effective than CD28 to 
promote T cell proliferation induced by CD3 and CD2 
stimulations (7). To explain this, it has been proposed that 
CD73+ cells may act as a specialized subset to amplify immune 
responses originated by CD3 and CD2 activation pathways: CD73+ 
cells fully activated by CD3/CD73 costimulation recruit CD73-
cells by secreting a number of cytokines (7). Indeed, large 
amounts of IL-2 are detected in the supernatant of CD3/CD73 
costimulated T cells (7). A role of CD73+ cells in the 
amplification of immune responses is consistent with its 
decrease in diseases characterized by impaired immune responses 
(8) • 
CD73 expression is restricted to naive (CD45RA+) CD8+ cells 
In the last years, it has become clear that a major 
functional distinction among T cells is whether or not they 
retain the immunological memory of previous antigen encounters. 
Memory and naive T cells can be discriminated because of a 
series of phenotypic differences. The most suitable markers to 
discriminate them are CD45 isoforms (9). Low molecular weight 
isoforms (CD45RO) are expressed by memory T cells, whereas high 
molecular weight isoforms are expressed by naive T cells 
(CD45RA). Beside phenotypic differences, memory and naive cells 
have different functional properties and activation 
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requirements. Memory cells (CD45RO+) respond much better to 
recall antigens or CD3 and CD2 stimulations. Their improved 
response has been ascribed to several causes: i) different 
profiles of cyto~ine production (9); ii) increased expression 
of accessory molecules (9); iii) pre-assembled organization of 
the CD3/TCR/CD4/CD8/CD45 transducing apparatus (10). Given the 
unique ability of CD73 to enhance T cell activation and given 
its heterogenous expression in CD8+ cells, we have investigated 
CD73 distribution in purified CD8+ CD45RA+ and CD8+ CD45RO+ 
cells. These subsets were negatively isolated by using the 
panning technique. Two sequential pannings with CD4 and CD45RA 
or CD45RO mAbs were done. Subsets were 85-95% pure as shown by 
cytofluorometric analyses. CD73 expression was evaluated by 
radiochemical and cytofluorometric analyses. Unexpectedly, CD73 
expression was found to be confined to naive (CD45RA+) cells 
(Dianzani et al., manuscript in preparation). This finding 
pointed out once more the unique characteristics of CD73 as an 
accessory molecule: so far, CD73 is the only accessory molecule 
overexpressed in naive rather than memory T cells. 
The peculiar expression of CD73 in naive cells may help to 
revise its role in the immune system and its deficiency in some 
diseases. One can speculate that its deficiency may reflect 
either an altered distribution of memory and naive cells or an 
impaired ability of naive cells to develop an effective 
immunological memory upon the first encounter with the antigen. 
In the first case, one should expect an enhanced response to 
recall antigens and/or CD3 and CD2 stimulations (11); in the 
latter case, one should find that CD73 has a role in the 
activation of CD45RA+ cells. Indeed, preliminary studies in our 
lab indicate that CD73 plays a crucial role in the activation 
of naive CD8+ cells by making these cells able to overcome 
their hyporeactivity to CD3 engagement. 
CONCLUSIONS 
It has been proved that CD73 is an important accessory 
molecule which can highly upregulate T cell activation. CD73 
expression is restricted to a small subset of CD3+ CD8+ CD11b-
CD45RA+ cells which are naive T cells containing alloreactive 
CTL precursors. These data may help to restrict the field on 
which future studies on CD73 should focus on. 
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